# Michelson Diagnostics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/michelson-diagnostics

- Industry: Medical Devices & Equipment
- Headquarters: UK
- Website: www.michelsondiagnostics.com
- Total disclosed funding: $7.3M
- Latest round: Series A (Nov 22, 2013)
- Investors on record: 3

## About

Michelson Diagnostics focuses on advanced medical imaging technology, particularly through its VivoSight® Optical Coherence Tomography (OCT) scanner, which enhances the diagnosis and monitoring of skin conditions.Founded in 2006 in the UK, Michelson Diagnostics specializes in advanced medical imaging solutions. The company has raised a total of GBP 2.5 million through various funding rounds, with the most recent being a Series B round in February 2015. Key investors include Kent County Council Superannuation Fund and Plus Orthopedics Holding AG. The company's headquarters is located in the UK, but specific global office locations are not disclosed.Michelson Diagnostics specializes in advanced medical imaging technology, primarily focusing on its flagship product, the VivoSight® Optical Coherence Tomography (OCT) scanner. This device provides high-resolution, real-time imaging of tissue structures, enabling healthcare professionals to diagnose and monitor various skin conditions, including cancerous lesions. The VivoSight OCT system enhances clinical decision-making in dermatology and other medical fields, serving hospitals, private clinics, and research institutions in regions such as the United Kingdom, United States, and Germany.In the most recent year of 2015, Michelson Diagnostics reported a revenue of GBP 973,659.4, with an EBITDA of GBP -3,937,870.2. The revenue primarily generated through the sale of VivoSight OCT systems, which are purchased directly by healthcare facilities. The company also provides ongoing support services and accessories for the OCT system, fostering long-term relationships with its customers.Michelson Diagnostics aims to expand its product offerings and enhance its market presence. The funding raised in February 2015 will support the development of new products and entry into additional markets. Specific geographic regions targeted for expansion include Europe and North America, with plans to launch these initiatives within the next few years. The company intends to leverage its Series B funding to further its technology and customer outreach.

## Funding rounds

- Series A, Nov 22, 2013, $3.2M — Catapult Ventures Group, London Business Angels, Octopus Investments
- Series A, Oct 31, 2011, $1M — Catapult Ventures Group, Octopus Investments
- Series A, Oct 8, 2010, $3.2M — Octopus Investments

## Investors

- Octopus Investments (https://capitalatlas.ai/funds/octopus-investments) — Series A
- Catapult Ventures Group (https://capitalatlas.ai/funds/catapult-ventures-group) — Series A
- London Business Angels — Series A